X-linked inhibitor of apoptosis (XIAP) inhibits c-Jun N-terminal kinase 1 (JNK1) activation by transforming growth factor beta1 (TGF-beta1) through ubiquitin-mediated proteosomal degradation of the TGF-beta1-activated kinase 1 (TAK1)
about
X-linked lymphoproliferative syndromes: brothers or distant cousins?Molecular mechanisms of liver injury and hepatocarcinogenesis: focusing on the role of stress-activated MAPKInflammation- and stress-related signaling pathways in hepatocarcinogenesisOncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.Analysis of inhibitor of apoptosis protein family expression during mammary gland development.Lysine 63-linked polyubiquitination of TAK1 at lysine 158 is required for tumor necrosis factor alpha- and interleukin-1beta-induced IKK/NF-kappaB and JNK/AP-1 activation.X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/2 tyrosine kinase inhibitor.Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiencyE3 ligase activity of XIAP RING domain is required for XIAP-mediated cancer cell migration, but not for its RhoGDI binding activityTransforming growth factor-β and the hallmarks of cancer.Molecular mechanisms underlying hepatocellular carcinomaInvolvement of the Edar signaling in the control of hair follicle involution (catagen).Angiotensin receptor blockade attenuates cigarette smoke-induced lung injury and rescues lung architecture in mice.Thioredoxin Activates MKK4-NFκB Pathway in a Redox-dependent Manner to Control Manganese Superoxide Dismutase Gene Expression in Endothelial Cells.A potential role of X-linked inhibitor of apoptosis protein in mitochondrial membrane permeabilization and its implication in cancer therapyImiquimod-induced apoptosis of melanoma cells is mediated by ER stress-dependent Noxa induction and enhanced by NF-κB inhibition.Lys48-linked TAK1 polyubiquitination at lysine-72 downregulates TNFα-induced NF-κB activation via mediating TAK1 degradation.Survival and apoptosis: a dysregulated balance in liver cancer.Nuclear factor-kB in thyroid carcinogenesis and progression: a novel therapeutic target for advanced thyroid cancer.XIAP downregulation promotes caspase-dependent inhibition of proteasome activity in AML cells.TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-betaX-linked inhibitor of apoptosis regulates lung fibroblast resistance to Fas-mediated apoptosis.IAP-targeted therapies for cancer.TAK1 mRNA expression in the tumor tissue of locally advanced head and neck cancer patients.X-linked inhibitor of apoptosis protein and its E3 ligase activity promote transforming growth factor-{beta}-mediated nuclear factor-{kappa}B activation during breast cancer progressionXIAP as a ubiquitin ligase in cellular signaling.The role and therapeutic implications of RING-finger E3 ubiquitin ligases in hepatocellular carcinoma.Barium inhibits arsenic-mediated apoptotic cell death in human squamous cell carcinoma cells.XIAP protects oligodendrocytes against cell death in vitro but has no functional role in toxic demyelination.XIAP gene expression and function is regulated by autocrine and paracrine TGF-beta signaling.Insufficiency of pro-heparin-binding epidermal growth factor-like growth factor shedding enhances hypoxic cell death in H9c2 cardiomyoblasts via the activation of caspase-3 and c-Jun N-terminal kinase.Oxidative inactivation of the proteasome in retinal pigment epithelial cells. A potential link between oxidative stress and up-regulation of interleukin-8.CXC receptor-2 knockout genotype increases X-linked inhibitor of apoptosis protein and protects mice from acetaminophen hepatotoxicityBrief Communication: Copper suppression of vascular endothelial growth factor receptor-2 is involved in the regression of cardiomyocyte hypertrophy.Activation of NADPH oxidase by transforming growth factor-beta in hepatocytes mediates up-regulation of epidermal growth factor receptor ligands through a nuclear factor-kappaB-dependent mechanism.Inhibitor of Apoptosis Proteins: Promising Targets for Cancer Therapy.Dysregulation of apoptosis in hepatocellular carcinoma cells.Over-expression of X-linked inhibitor of apoptosis protein modulates multiple aspects of neuronal Ca2+ signaling.Functional Genomics Approach Identifies Novel Signaling Regulators of TGFα Ectodomain Shedding.
P2860
Q27690253-3E0B695F-1D8D-4915-857C-504E6BADFED5Q28384866-81D88D1A-483D-4EB9-842C-E28B36A46BB5Q28387669-0175DF21-D027-4CC7-98B4-4BA63EE7445DQ33298434-DDE44FFF-426B-4525-9BC2-8F5E1CD5AAA9Q33618500-FB1B867B-E2E1-4EA6-B418-968BB2962491Q33648347-FE1CE2ED-5295-49D6-9682-F643C3169B87Q34214918-A4CFC48C-3042-4A75-8683-42E373D40F60Q34242492-91421443-FD69-45F4-A889-256FC107D658Q34245177-C5FF72CB-90E4-444A-A6D4-0D43023445D6Q34789300-BD7F7B2B-D7A0-4A28-A0B9-5A15B7F32D78Q35260040-D354CA71-AF5F-4672-9853-85685817AB67Q35569831-19CC6A09-FB5A-41BE-A7D2-AC288C4A7EC8Q35640559-AF17FEFF-DAE3-42F1-95BB-0F03531D94A5Q35837205-20A8698F-A745-4255-AAC0-4DB9CE12F912Q36495236-D32795F0-B76F-4361-AA57-821BD13AC35EQ36504317-2A017C9F-4E04-4A91-8359-4F388DD3D4E8Q36632268-A221C32C-EF5E-4A9C-8BC5-9FAD9832E7A4Q36740628-9E000408-35EE-45AA-B991-8F66839CBF44Q36949801-DBDBC470-2F33-4674-A3B0-722805BE41A8Q36980231-B281462B-8149-488B-B493-D4C0126FBB7EQ37052635-22DB561A-8B2C-497B-BA2F-A9AD38359D26Q37056479-00814975-ACFC-4DD0-A052-58FC97A65A3EQ37302745-92E43E1C-AAC5-4BED-8E63-C58BFC770837Q37321864-950156BE-DFD0-43E0-86F8-7AD4AB9DCAC2Q37372003-D4194768-A0B6-4BB8-8AF8-683630429926Q37546803-6F730458-DD82-45F1-9009-3701A0BBE854Q38178169-684593D6-7376-44EB-8E35-E370BFC81978Q39360429-C8E4B1F7-14ED-456A-A801-8E90F05099D3Q39446591-62486348-0A9C-4DF0-B948-8A7DE49FCDF5Q39667150-4EDBD2A2-5823-4AE4-ACAC-B5F3CFEB6F62Q39887473-1063CD90-F9C8-4847-8925-4F0BE713D2D7Q39978747-9351CD77-A1D1-4E05-98CD-B10A6214B2ACQ41899192-ECCE88CC-6256-4345-A281-A7A0307F1F51Q42705343-4822115F-89DC-471E-932F-C8B8958EFC27Q42734722-87A4EB81-8A6B-4AE5-A38A-41F6F6CC3704Q42949488-8FD2B67D-43FF-4162-891A-42898322B541Q43166036-EBA12211-619D-471A-BB61-274DAE7EBD5FQ45068490-E539AC2F-1E12-48F4-987C-0B360B522135Q47582263-15595708-A321-4392-9747-CA26A97EA6A6
P2860
X-linked inhibitor of apoptosis (XIAP) inhibits c-Jun N-terminal kinase 1 (JNK1) activation by transforming growth factor beta1 (TGF-beta1) through ubiquitin-mediated proteosomal degradation of the TGF-beta1-activated kinase 1 (TAK1)
description
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2005
@ast
im November 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/11/18)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/11/18)
@nl
наукова стаття, опублікована в листопаді 2005
@uk
name
X-linked inhibitor of apoptosi ...... eta1-activated kinase 1 (TAK1)
@ast
X-linked inhibitor of apoptosi ...... eta1-activated kinase 1 (TAK1)
@en
X-linked inhibitor of apoptosi ...... eta1-activated kinase 1 (TAK1)
@nl
type
label
X-linked inhibitor of apoptosi ...... eta1-activated kinase 1 (TAK1)
@ast
X-linked inhibitor of apoptosi ...... eta1-activated kinase 1 (TAK1)
@en
X-linked inhibitor of apoptosi ...... eta1-activated kinase 1 (TAK1)
@nl
prefLabel
X-linked inhibitor of apoptosi ...... eta1-activated kinase 1 (TAK1)
@ast
X-linked inhibitor of apoptosi ...... eta1-activated kinase 1 (TAK1)
@en
X-linked inhibitor of apoptosi ...... eta1-activated kinase 1 (TAK1)
@nl
P2093
P2860
P356
P1476
X-linked inhibitor of apoptosi ...... eta1-activated kinase 1 (TAK1)
@en
P2093
Manickam Venkatraman
Marcello Arsura
Swayamjot Kaur
P2860
P304
38599–38608
P356
10.1074/JBC.M505671200
P407
P577
2005-11-18T00:00:00Z